| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/20/2001 | US6191256 Recombinant factor VIII binding peptides |
| 02/20/2001 | US6191166 Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| 02/20/2001 | US6190920 By cleaving two amino acid residue groups, one attached to a dye, the other a resin, the groups linked by group cleavable under conditions that do not cleave an amide; cyclization is detected by retention of dye on resin; peptidase inhibitors |
| 02/20/2001 | CA2232878C Liquid detergents with ortho-substituted phenylboronic acids for inhibition of proteolytic enzymes |
| 02/20/2001 | CA2225412C A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component |
| 02/20/2001 | CA2158991C Adipocyte differentiation inhibiting peptide and adipocyte differentiation inhibiting agent using the peptide as active component thereof |
| 02/15/2001 | WO2001010894A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/15/2001 | WO2001010893A2 Il-16 antagonists |
| 02/15/2001 | WO2001010891A2 Il-16 antagonists |
| 02/15/2001 | WO2001010890A2 Process of synthesis of fluorescent protease substrates |
| 02/15/2001 | WO2001010851A1 Process for the preparation of lysine-carboxyanhydride intermediates in the synthesis of lisinopril |
| 02/15/2001 | WO2001010845A1 Novel diketopiperazines |
| 02/15/2001 | WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 02/15/2001 | WO2001010798A1 Solid phase synthesis of oxa- and thiazoles |
| 02/15/2001 | WO2001010457A2 Pharmaceutical compositions containing tripeptides |
| 02/15/2001 | WO2001010456A2 Peptides that block viral infectivity and methods of use thereof |
| 02/15/2001 | WO2000064946A3 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 02/15/2001 | DE19937721A1 Neue Diketopiperazine New Diketopiperazines |
| 02/15/2001 | CA2380647A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/15/2001 | CA2378480A1 Pharmaceutical compositions containing tripeptides |
| 02/15/2001 | CA2378460A1 Peptides that block viral infectivity and methods of use thereof |
| 02/14/2001 | EP1076064A1 Novel aspartame derivative crystal and process for producing the same |
| 02/14/2001 | EP1076063A1 Novel aspartame derivative crystal and process for producing the same |
| 02/14/2001 | EP1076062A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 02/14/2001 | EP1076056A1 Novel spiro compounds or salts thereof and preventives/remedies for autoimmune diseases and ap-1 inhibitors containing the same |
| 02/14/2001 | EP1075797A1 Novel sweetener compositions |
| 02/14/2001 | EP1075796A1 Sweetener compositions |
| 02/14/2001 | EP0815120B1 17-difluoromethylene-oestratrienes |
| 02/14/2001 | CN1284086A Conjugates useful in treatment of prostate cancer |
| 02/14/2001 | CN1284084A Echinocandin derivatives, prepn. method and application as anti-fungal agents |
| 02/14/2001 | CN1284063A Compounds |
| 02/14/2001 | CN1284060A Novel metalloproteinase inhibitors |
| 02/14/2001 | CN1284058A Neuroprotective agents |
| 02/13/2001 | US6187993 Transgenic animals as model of psoriasis |
| 02/13/2001 | US6187800 Method for the prevention and treatment of mastitis |
| 02/13/2001 | US6187771 Tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes |
| 02/13/2001 | CA2147808C Acetylenic biaromatic compounds containing an adamantyl group; pharmaceutical and cosmetic compositions containing them and uses thereof |
| 02/08/2001 | WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 02/08/2001 | WO2001009188A1 Binding moieties for fibrin |
| 02/08/2001 | WO2001009173A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 02/08/2001 | WO2001009169A2 Cysteine protease inhibitors |
| 02/08/2001 | WO2001009168A1 A METHOD FOR THE PURIFICATION OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
| 02/08/2001 | WO2001008677A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | WO2000066528A3 Quinones for treatment of diseases |
| 02/08/2001 | WO2000063247A3 Osteopontin-derived chemotactic and inhibitory agents and uses therefor |
| 02/08/2001 | CA2647796A1 Method of inhibiting osteoclast activity |
| 02/08/2001 | CA2388663A1 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 02/08/2001 | CA2380578A1 Ring opened cpis |
| 02/08/2001 | CA2380007A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | CA2376245A1 Binding moieties for fibrin |
| 02/07/2001 | EP1074559A1 Peptide nucleic acids |
| 02/07/2001 | EP1073674A1 Thiol inhibitors of endothelin-converting enzyme |
| 02/07/2001 | EP1073673A1 NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS |
| 02/07/2001 | EP1073672A1 Antipicornaviral compounds, their preparation and use |
| 02/07/2001 | EP1073453A1 Methods to increase white blood cell survival after chemotherapy |
| 02/07/2001 | EP1073449A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
| 02/07/2001 | EP0943096A4 A PROTEIN PREPARATION THAT MEDIATES Ca2+ -DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF |
| 02/07/2001 | EP0562025B1 Compounds and their use in a binary synthesis strategy |
| 02/07/2001 | CN1283201A K receptor opioid peptides |
| 02/07/2001 | CN1283188A Bisulfate salt of HIV protease inhibitor |
| 02/07/2001 | CN1282737A Intermediate product used for preparing substituted quinoline-2-formamide |
| 02/07/2001 | CN1282731A Process for preparing alpha, omega, delta-tribenzyloxycarbonyl arginine |
| 02/06/2001 | US6184345 Stable under solid phase synthesis conditions |
| 02/06/2001 | US6184244 C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/06/2001 | US6184223 Reverse-turn mimetics and methods relating thereto |
| 02/06/2001 | US6184210 Dipeptide-based caspase (proteolytic family of cysteine proteases whose active site cysteine residue is essential for ice-mediated apoptosis) inhibitors of given formula are potent inhibitors of apoptosis |
| 02/06/2001 | US6184208 Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| 02/06/2001 | US6184205 Purified peptide of given amino acid sequences that binds to the n-terminal sh3 domain of grb2; useful in modulating signal transduction pathways at the cellular level, in modulating oncogenic protein activity |
| 02/06/2001 | US6184200 Truncated glial cell line-derived neurotrophic factor |
| 02/01/2001 | WO2001007467A1 Streptogramin derivatives, preparation and compositions containing same |
| 02/01/2001 | WO2001007425A1 Method for producing 2-aminomethyl-4-cyano-thiazol |
| 02/01/2001 | WO2001007419A1 Novel thiazine or pyrazine derivatives |
| 02/01/2001 | WO2001007407A1 Lactam inhibitors of hepatitis c virus ns3 protease |
| 02/01/2001 | WO2001007400A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
| 02/01/2001 | WO2001007042A1 Apicidin-derived cyclic tetrapeptides |
| 02/01/2001 | WO2001007033A2 Neuroprotective pharmaceutical reparations comprising p-fluoroselegiline |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 02/01/2001 | WO2000003743A3 Use of inhibitors of prenyltransferases for inhibiting fungal growth |
| 02/01/2001 | CA2382757A1 Carboxylic acid derivatives and adhesion molecule inhibitors which contain the same as effective ingredients |
| 02/01/2001 | CA2380218A1 Novel thiazine or pyrazine derivatives |
| 02/01/2001 | CA2378849A1 Apicidin-derived cyclic tetrapeptides |
| 02/01/2001 | CA2376961A1 Lactam inhibitors of hepatitis c virus ns3 protease |
| 01/31/2001 | EP1072608A1 Glutathione derivatives and dosage forms thereof |
| 01/31/2001 | EP1071698A1 Nucleic acid sequences and proteins associated with aging |
| 01/31/2001 | EP1071442A1 Methods and compositions for peptide synthesis |
| 01/31/2001 | CN1282336A Hemiasterlin analogs |
| 01/31/2001 | CN1282253A Small peptides and method for treatment of asthma and inflammation |
| 01/31/2001 | CN1282222A Sweetener compositions containing aspartame and aspartame derivative |
| 01/31/2001 | CN1061339C Novel sulfonamide inhibitors of aspartyl protease |
| 01/30/2001 | US6180759 Process for the preparation of azacycloalkylakanoyl pseudotetrapeptides |
| 01/30/2001 | US6180646 Retroviral protease inhibitors |
| 01/30/2001 | US6180627 Antithrombotic agents |
| 01/30/2001 | US6180619 Prenyl transferase inhibitors |
| 01/30/2001 | US6180618 Propanolamine derivatives linked to bile acids, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/30/2001 | US6180611 Inhibitors of matrix metalloproteinases and tumor necrosis factor |
| 01/30/2001 | US6180600 CD8 antagonists |
| 01/30/2001 | US6180362 Peptides which inhibit ras protein activity, their preparation and use |
| 01/30/2001 | US6180157 Providing premix solution comprising n-(n-(3,3-dimethylbutyl)-l-.alpha.-aspartyl)-l-phenylalanine 1-methyl ester and binding agent; heating; fluidizing carrier; applying premix solution onto carrier to form agglomerate |
| 01/30/2001 | US6180156 As liquid low-calorie sweetener |